Aron

Aron Pharma is a Polish pharmaceutical and biotechnology company focused on the development of innovative medical products, dietary supplements, and medical devices based on standardized plant extracts and polyphenols. The company specializes in utilizing the therapeutic potential of Aronia melanocarpa (chokeberry) and other natural compounds to address metabolic and cardiovascular health. Their research and development efforts are centered on creating evidence-based formulations that target oxidative stress, inflammation, and glucose metabolism. Aron Pharma's product portfolio includes brands such as Berroxin and Aroniaberry, which are marketed for immune support and metabolic regulation. The company maintains a strong focus on clinical validation and high-quality manufacturing standards to bridge the gap between traditional herbal medicine and modern pharmacology.